DISP1 Inhibitors
DISP1 Inhibitors are a collection of chemical entities that attenuate the activity of DISP1 by modulating the Hedgehog (Hh) signaling pathway at various control points. For example, compounds like cyclopamine, jervine, and robotnikinin act as steroidal alkaloids or small molecules that bind to and inhibit Smoothened (SMO), a critical transmembrane protein in the Hh pathway. This blockade of SMO prevents the proper transduction of the Hh signal, reducing the requirement for DISP1's role in secreting the Hh ligand. Similarly, vismodegib, erismodegib, saridegib, taladegib, glasdegib, patidegib, and SANT-1 are all specific antagonists of SMO that diminish DISP1's functional activity by ensuring that the downstream signaling events, normally activated by the Hh ligand, are suppressed. By inhibiting SMO, these compounds indirectly lessen the necessity for DISP1's ligand release function, therefore achieving an inhibitory effect on DISP1 without directly targeting the protein.
Furthermore, DISP1 activity is influenced indirectly by the disruption of the transcriptional outcomes of the Hh pathway. GANT61 specifically targets GLI transcription factors, which are downstream effectors in the Hh signaling cascade. The inhibition of GLI by GANT61 weakens the transcriptional activation of Hh target genes, which in turn curtails the need for DISP1-mediated Hh ligand release. By impeding critical elements of the Hh pathway, these DISP1 inhibitors collectively contribute to the reduced functional activity of DISP1, effectively diminishing its role in the pathway without the necessity for direct interaction with the protein itself. Each inhibitor, through its unique mechanism of action on the diverse constituents of the Hh pathway, ensures that the biological processes requiring DISP1's participation are downregulated, thereby achieving inhibition of DISP1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine is a steroidal alkaloid that inhibits the Hedgehog (Hh) signaling pathway by directly targeting Smoothened (SMO), which is a vital component for the activation of the pathway. By inhibiting SMO, cyclopamine indirectly diminishes DISP1 activity, as DISP1 is essential for the release of the Hh ligand that activates downstream signaling. | ||||||
GANT61 | 500579-04-4 | sc-202630 sc-202630A sc-202630B | 1 mg 5 mg 10 mg | $64.00 $131.00 $204.00 | 6 | |
GANT61 is a small molecule that targets GLI transcription factors, key components of the Hedgehog (Hh) signaling pathway. By inhibiting GLI, GANT61 indirectly leads to the reduced functional activity of DISP1 by diminishing the transcriptional activation of Hh target genes, consequently reducing the need for DISP1-mediated Hh ligand release. | ||||||
Jervine | 469-59-0 | sc-200934 sc-200934A | 1 mg 5 mg | $66.00 $240.00 | 1 | |
Jervine is a naturally occurring steroidal alkaloid that inhibits the Hh signaling pathway by antagonizing Smoothened (SMO). By targeting SMO, jervine indirectly lowers DISP1 activity, as it prevents the signal transduction necessary for the Hh ligand to exert its effects, ultimately decreasing the functional requirement for DISP1-mediated ligand secretion. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Vismodegib is a potent inhibitor of Smoothened (SMO), a critical receptor in the Hedgehog (Hh) signaling pathway. By binding to and inhibiting SMO, vismodegib indirectly reduces the activity of DISP1, as it blocks the Hh pathway downstream of DISP1, thus decreasing the demand for DISP1's role in Hh ligand release. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
Erismodegib is a selective antagonist of Smoothened (SMO), which is part of the Hedgehog (Hh) signaling pathway. It inhibits the pathway downstream of DISP1 by binding to SMO, thereby indirectly diminishing the functional activity of DISP1 by reducing the pathway's requirement for the DISP1-mediated release of the Hh ligand. | ||||||
Saridegib | 1037210-93-7 | sc-507351 | 5 mg | $3500.00 | ||
Saridegib is another SMO antagonist that suppresses the Hedgehog (Hh) signaling pathway at the level of SMO. By inhibiting SMO, saridegib indirectly decreases DISP1's functional activity, as the inhibition of SMO reduces the need for DISP1's function in secreting the Hh ligand necessary for pathway activation. | ||||||
Glasdegib | 1095173-27-5 | sc-507353 | 5 mg | $165.00 | ||
Glasdegib works as a SMO antagonist, which indirectly leads to the inhibition of DISP1 by obstructing the Hedgehog (Hh) signaling pathway. The blockade of SMO by glasdegib diminishes the pathway's reliance on DISP1 for the secretion of the Hh ligand, effectively reducing DISP1's functional necessity. | ||||||
SANT-1 | 304909-07-7 | sc-203253 | 5 mg | $135.00 | 5 | |
SANT-1 is a potent Smoothened (SMO) antagonist that indirectly suppresses DISP1 activity by inhibiting the Hedgehog (Hh) signaling pathway. The inhibition of SMO by SANT-1 diminishes the need for DISP1 to secrete the Hh ligand, which is crucial for pathway activation. | ||||||
Robotnikinin | 1132653-79-2 | sc-396554 | 1 mg | $650.00 | 1 | |
Robotnikinin is a small molecule that binds to and inhibits Smoothened (SMO), directly affecting the Hedgehog (Hh) signaling pathway. This inhibition indirectly reduces the functional activity of DISP1 by lowering the requirement for DISP1's role in the secretion of the HProtein name = DISP1 | ||||||